Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina TbkISX:HEAL -3.62%67 Piotroski F-Score is 5 as of Aug. 23, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates ISX:HEAL with a GF Score™ of 67/100 and a GF Value™ of Rp1,563.15 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 645 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks better than 56.59% on this metric.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
PT Medikaloka Hermina Tbk has an F-score of 5 indicating the company's financial situation is typical for a stable company.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's Piotroski F-Score or its related term are showing as below:
ISX:HEAL'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 6 Max: 8
Current: 5
During the past 11 years, the highest Piotroski F-Score of PT Medikaloka Hermina Tbk was 8. The lowest was 3. And the median was 6.
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
PT Medikaloka Hermina Tbk Piotroski F-Score Related Terms
PT Medikaloka Hermina Tbk Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:HEAL vs HCA, THC, DVA: Piotroski F-Score Comparison
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk Piotroski F-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This Year (Jun26) TTM:
Last Year (Jun25) TTM:
Net Income was 131170 + 73530 + 101262 + 91916 = Rp397,878 Mil. Cash Flow from Operations was 329702 + 358302 + 248832 + 271506 = Rp1,208,342 Mil. Revenue was 1899407 + 1845570 + 1783206 + 1826203 = Rp7,354,386 Mil. Gross Profit was 580100 + 642483 + 619365 + 616797 = Rp2,458,745 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(11922503 + 11805141 + 11887060 + 12079165 + 11992249) / 5 = Rp11937223.6 Mil. Total Assets at the begining of this year (Jun25) was Rp11,922,503 Mil. Long-Term Debt & Capital Lease Obligation was Rp3,033,278 Mil. Total Current Assets was Rp2,224,782 Mil. Total Current Liabilities was Rp1,750,386 Mil.
Net Income was 125003 + 67782 + 124729 + 100118 = Rp417,632 Mil.
Revenue was 1682272 + 1690651 + 1692471 + 1696090 = Rp6,761,484 Mil. Gross Profit was 593836 + 556988 + 615205 + 576563 = Rp2,342,592 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(9881087 + 10160101 + 10577680 + 10828822 + 11922503) / 5 = Rp10674038.6 Mil. Total Assets at the begining of last year (Jun24) was Rp9,881,087 Mil. Long-Term Debt & Capital Lease Obligation was Rp3,199,312 Mil. Total Current Assets was Rp2,891,348 Mil. Total Current Liabilities was Rp1,639,885 Mil.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
PT Medikaloka Hermina Tbk's current Net Income (TTM) was 397,878.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
PT Medikaloka Hermina Tbk's current Cash Flow from Operations (TTM) was 1,208,342.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
PT Medikaloka Hermina Tbk's return on assets of this year was 0.03337202. PT Medikaloka Hermina Tbk's return on assets of last year was 0.0422658.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
PT Medikaloka Hermina Tbk's gearing of this year was 0.25410247. PT Medikaloka Hermina Tbk's gearing of last year was 0.29972835.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
PT Medikaloka Hermina Tbk's current ratio of this year was 1.27102365. PT Medikaloka Hermina Tbk's current ratio of last year was 1.76314071.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
PT Medikaloka Hermina Tbk's number of shares in issue this year was 15263.788. PT Medikaloka Hermina Tbk's number of shares in issue last year was 15365.95.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
PT Medikaloka Hermina Tbk's gross margin of this year was 0.33432363. PT Medikaloka Hermina Tbk's gross margin of last year was 0.34646122.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
PT Medikaloka Hermina Tbk's asset turnover of this year was 0.61684916. PT Medikaloka Hermina Tbk's asset turnover of last year was 0.68428544.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
1
+
1
+
0
+
1
+
0
+
0
=
5
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
PT Medikaloka Hermina Tbk has an F-score of 5 indicating the company's financial situation is typical for a stable company.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Piotroski F-Score of 5 as of Aug. 23, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, PT Medikaloka Hermina Tbk's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #280 out of 645 companies in the Healthcare Providers & Services industry, placing it in the top 43.4%.
Is PT Medikaloka Hermina Tbk's Piotroski F-Score too high?
PT Medikaloka Hermina Tbk's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. PT Medikaloka Hermina Tbk's value of 5 is 0% at this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #280 out of 645 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #280 out of 645 companies for Piotroski F-Score. This puts PT Medikaloka Hermina Tbk in the upper half of its industry. The industry median Piotroski F-Score is 5.00. PT Medikaloka Hermina Tbk's value of 5 is 0% at this benchmark. Historically, PT Medikaloka Hermina Tbk's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, PT Medikaloka Hermina Tbk has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,563.15, compared to a current price of Rp665.00 — trading 57.5% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Healthcare Providers & Services industry median of 5.00. PT Medikaloka Hermina Tbk's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Piotroski F-Score is 5 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp665.00 is trading 57.5% below its estimated GF Value™ of Rp1,563.15.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
GF Value™: Rp1,563.15 vs. price of Rp665.00 (57.5% below fair value)
Industry Position: 0% at the Healthcare Providers & Services median (#280 of 645)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
67GF Score
Get the complete analysis for ISX:HEAL
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
